About Manus Neuro
Manus Neuro is a company based in Motherwell (United Kingdom) founded in 2008 by Rutger Zietsma.. Manus Neuro has raised $5.79 million across 5 funding rounds from investors including Scottish Enterprise, North East Fund and Par Equity. The company has 6 employees as of June 30, 2020. Manus Neuro offers products and services including NeuroMotor Pen and NeuroMotor Pen App. Manus Neuro operates in a competitive market with competitors including Luciole Medical, CND Life Sciences, PD Neurotechnology, NeuroKaire and Rhaeos, among others.
- Headquarter Motherwell, United Kingdom
- Employees 6 as on 30 Jun, 2020
- Founders Rutger Zietsma
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Manus Neurodynamica Ltd
- Date of Incorporation 14 Aug, 2008
- Jurisdiction NORTH SHIELDS, TYNE AND WEAR
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.79 M (USD)
in 5 rounds
-
Latest Funding Round
$3.22 M (USD), Series A
May 25, 2023
-
Investors
Scottish Enterprise
& 7 more
-
Employee Count
6
as on Jun 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Manus Neuro
Manus Neuro offers a comprehensive portfolio of products and services, including NeuroMotor Pen and NeuroMotor Pen App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assesses fine motor skills to aid in diagnosing neuromotor disorders like Parkinson's.
Analyzes data from device for clinical monitoring and differential diagnosis.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Manus Neuro
Manus Neuro has successfully raised a total of $5.79M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3.22 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $3.2M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series A - Manus Neuro | Valuation | North East Fund , Par Equity | |
| Apr, 2021 | Amount | Grant - Manus Neuro | Valuation |
investors |
|
| Jan, 2021 | Amount | Seed - Manus Neuro | Valuation | Northstar Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Manus Neuro
Manus Neuro has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, North East Fund and Par Equity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment finance is provided to small and medium-sized enterprises.
|
Founded Year | Domain | Location | |
|
Venture capital and natural capital investments are managed by Par Equity.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on social impact companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Manus Neuro
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Manus Neuro
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Manus Neuro Comparisons
Competitors of Manus Neuro
Manus Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Luciole Medical, CND Life Sciences, PD Neurotechnology, NeuroKaire and Rhaeos, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Brain monitoring devices and analytics platforms are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of a neurological disease diagnostic tool for providers
|
|
| domain | founded_year | HQ Location |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| domain | founded_year | HQ Location |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| domain | founded_year | HQ Location |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Manus Neuro
Frequently Asked Questions about Manus Neuro
When was Manus Neuro founded?
Manus Neuro was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Where is Manus Neuro located?
Manus Neuro is headquartered in Motherwell, United Kingdom. It is registered at Motherwell, Scotland, United Kingdom.
Who is the current CEO of Manus Neuro?
Rutger Zietsma is the current CEO of Manus Neuro. They have also founded this company.
Is Manus Neuro a funded company?
Manus Neuro is a funded company, having raised a total of $5.79M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.64M, raised on Jun 01, 2018.
How many employees does Manus Neuro have?
As of Jun 30, 2020, the latest employee count at Manus Neuro is 6.
What does Manus Neuro do?
Manus Neuro was founded in 2008 and is based in Motherwell, United Kingdom. Devices for identifying biomarkers of neuromotor impairments are offered by the company, supporting screening, rehabilitation, drug development, and medicine optimization. Referrals are streamlined, and costs for specialist services are reduced through these tools. A digital sensor pen has been developed for handwriting assessment, aiding diagnosis and monitoring of Parkinsons disease in clinical settings.
Who are the top competitors of Manus Neuro?
Manus Neuro's top competitors include CND Life Sciences, NeuroKaire and Seer.
What products or services does Manus Neuro offer?
Manus Neuro offers NeuroMotor Pen and NeuroMotor Pen App.
Who are Manus Neuro's investors?
Manus Neuro has 8 investors. Key investors include Scottish Enterprise, North East Fund, Par Equity, SIS Ventures, and Old College Capital.